FDA Says Psychedelic Drug Applications Now “Fully a Third” of Workload
Federal officials are signaling growing momentum behind psychedelic drug development. The flood of applications reflects broad enthusiasm.
Read More
GLP-1 Providers Can Now Drive New Revenue Streams Through Diagnostic Bundling
The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change that equation entirely. Key Takeaway Details Revenue per patient $40 per consult (three times per year) For every 100 patients You earn $12,000 annually (this is in incremental to medication or visit revenues) Operational lift […]
Read More
New Study Reveals What Happens to Your Brain on the World’s Most Powerful Psychedelic
Scientist captured the first detailed look at how 5-MeO-DMT reshapes brain activity which challenge long held assumptions.
Read More
New Research Points to TMS and Ketamine as a Powerful Combination for Treatment Resistant Conditions
Researchers are finding that combining TMS with ketamine therapy produces better outcomes than either treatment alone.
Read More
Texas Medical Board Proposes Sweeping New Rules for Ketamine Clinics
This proposal introduces mandatory registration for clinics and establishes strict standards for patient monitoring.
Read More
Researchers Identify Brain Receptor That Could Unlock Safer Psilocybin Treatments
Psilocybin has shown promise for treating depression, but its hallucinogenic effects create barriers. A new study may change that.
Read More
Ohio Psychedelic Crisis Response Training Program Continues to Move Forward
Ohio has become the first in the nation to offer specialized training for professionals who encounter people experiencing psychedelic crises.
Read More
FDA Clears Compass Pathways to Begin Late Stage Psilocybin Trial for PTSD
This FDA decision represents meaningful progress. A new option may finally be on the horizon for those suffering PTSD.
Read More
Mystical Experiences During Ibogaine Linked to Greater PTSD Relief in Veterans
A new study from Stanford University offers fresh insight into how ibogaine may help combat veterans heal from trauma.
Read More
DEA Extends Telehealth Rules for Controlled Substances Through 2026
Telehealth ketamine companies can continue operating under familiar rules. Nothing changes in the new year.
Read More